HSBC Highlights Resilient Sectors Amid Market Turmoilby Mark Eisenberg 11.08.2024HSBC analysts focus on Healthcare, Industrials, and the UK market for stability during European stock selloff.
Top Defensive Biotech Stocks Amid Market Turmoilby Lilu Anderson 10.08.2024Discover Piper Sandler's eight high-quality defensive biotech stocks poised to thrive in volatile markets.
Natera Inc. Reports Strong Revenue Growth in Q2 2024by Mark Eisenberg 10.08.2024Natera Inc. sees a 58% revenue surge in Q2 2024, driven by high test volumes and ASP growth, raising guidance ...
23andMe Reports Q1 Revenue Drop, Narrows Lossesby Mark Eisenberg 10.08.202423andMe's Q1 revenue declines by 34% but narrows losses. Focus on AI and genetic studies drives future growth.
Organogenesis Q2 Revenue Surpasses Forecasts at $130Mby Mark Eisenberg 10.08.2024Organogenesis exceeds Q2 revenue expectations at $130.2M, driven by robust sales and strategic growth plans.
Biotech Stocks to Buy in Market Downturnby Lilu Anderson 08.08.2024Explore top biotech stocks poised for growth amid market challenges. Learn about innovations and opportunities in gene therapy.
Roche Considers Divesting $1.9 Billion Cancer Data Startupby Mark Eisenberg 07.08.2024Roche is evaluating options for its $1.9 billion investment in Flatiron Health, potentially including divestment.
Novanta Beats Q2 Expectations with 3% Revenue Growthby Mark Eisenberg 07.08.2024Novanta Inc. surpasses market expectations with a 3% revenue growth in Q2 2024. Adjusted EBITDA and operating cash flow also ...
Formation Bio Lands $372M Series D Amid AI-Driven Expansionby Lilu Anderson 26.06.2024Formation Bio secures $372M Series D led by Sanofi to enhance AI-driven drug development, focusing on workflow automation and AI ...
AI in Ultrasound Imaging Market to Hit $1733M by 2031by Lilu Anderson 25.06.2024Artificial Intelligence in Ultrasound Imaging Market to grow from USD 889.16 million in 2023 to USD 1733.08 million by 2031 ...